Navigation Links
Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
Date:5/1/2008

ROCHESTER, N.Y., May 1 /PRNewswire/ -- Bio-Optronics announced Thursday that a majority of the company's shares had been acquired by Dan Kerpelman, who will be joining the healthcare workflow technology company as President and CEO.

Kerpelman brings over thirty years of executive experience to Bio-Optronics, a healthcare workflow technology provider with headquarters in Rochester, NY. The company's product portfolio includes innovative workflow management and optimization solutions for hospitals, specialty medical practices and clinical researchers. Kerpelman plans to lead the company through an expansion of its current product offerings and into new markets both within the U.S. and Europe.

Kerpelman explained the decision to join Bio-Optronics by saying, "I've been seeking to leverage my multinational healthcare technology experience in a more entrepreneurial environment. I am so pleased and proud to partner with Mike Kamish and his team. Their innovative products and services have created solutions to some of healthcare's most challenging problems, and we are all enthusiastic to work together to take Bio-Optronics to new heights."

The company's former President and CTO, Mike Kamish, will remain in the role of Vice President and CTO. Kamish said, "We are delighted with Dan's commitment to Bio-Optronics. His experience in the field of healthcare technology and his management experience at GE Healthcare, Kodak Health Imaging, and SGS will be a tremendous asset to the future growth of the company."

Later this month, the company will introduce a new corporate logo, product branding scheme and website, emphasizing its focus on innovative healthcare workflow technology.

About Dan Kerpelman

Dan Kerpelman has thirty years of professional experience, mostly in healthcare technology. He was recently CEO of the Societe Generale de Surveillance in Geneva, Switzerland where he led a $3.5B services company of 46,000 employees, inc
'/>"/>

SOURCE Bio-Optronics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Pers...s set to take place on February 22-24, 2010 in Phi...onference we will highlight key issues in forming ... their experiences. , Min...a for Arrowhead’s 2010 Personalized Medicin...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...N.J., Nov. 5 DSM Pharmaceutical Pr...uring alliance with Galenix, Saint Jean D,Illac, F...scale manufacturing partner for Galenix commercial... will collaborate on business development opportun...ies, based on the strength of Galenix in drug prod...
(Date:11/5/2009)...VA, Calif., Nov. 5 Therm...r of innovative products for processing and storin... first quarter of fiscal 2010. ,, For the quart...revenues of $5.2 million, a 15 percent increase ov... year ago. The Company said the key contributors t...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
..., Wis. - In the aftermath of a critical state au...efending the economic development work being done ...n Neis, co-founder and senior partner of Venture ...he Legislative Audit Bureau are incomplete and p...by the so-called CAPCOs, which include Venture Inv...
...lis, Wis. - Merge Technologies Inc. , a provide...ation technology under the name Merge Healthcare, ...e Nasdaq Stock Market warning that the company r...opportunity to file financial reports. , ,The comp...arter ended June 30 would serve as an additional b...
..., Wis. - The next generation of high-performance ...als, according to engineering researchers at the ... no ordinary crystals. Teams of scientists across ... making, are examining a material called ultranan...ical systems into which it could be integrated. , ...
Other Biology Technology:Venture capitalist defends Wisconsin CAPCOs 2Venture capitalist defends Wisconsin CAPCOs 3Nano-diamond film studied at UW could advance telecommunications 2Nano-diamond film studied at UW could advance telecommunications 3
(Date:11/4/2009)...dors in the cities of Long Beach and Riverside are...ntable childhood asthma, and the true impact of ai...likely been underestimated, according to researche... , The study, which appears in an online editio...mated that nine percent of all childhood asthma ca...
(Date:11/4/2009)... Calif., Oct. 19 Spectros, develop...and imaging devices which shed light on life-threa...d exclusive distribution deals for both its T-Stat...ts covered include Australia, New Zealand, The Ne..., Italy, France, Spain, Portugal, Poland, Greece, ...
(Date:11/4/2009)...., Oct. 23 GenVault Corporation, t...ent for genomic discovery, medicine and identifica...nVault,s President and CEO, will be presenting at ...ober 26th and 27th in La Jolla, CA. ,, During t...ew of the company together with recent customer, t...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Congress Must Recognize Homecare as Cost Effective Part of Health Care Reform 52156 1Congress Must Recognize Homecare as Cost Effective Part of Health Care Reform 52156 2Congress Must Recognize Homecare as Cost Effective Part of Health Care Reform 52156 3More Americans Have Cell Phones Than Dental Coverage 52153 1More Americans Have Cell Phones Than Dental Coverage 52153 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 3
... a blueprint for artificial cells that are more po...imic and could one day be used to power tiny medic...stion of whether an artificial version of the elec...els could be designed as a potential power source...g electricity," said Jian Xu, a postdoctoral assoc...
...e has been developed by researchers at UC Davis le...The inexpensive, publicly-available rice DNA micro...ce genome. Details are published this week in the ...isms, such as humans or rice plants, each cell typ...ntists have developed high-throughput methods to e...
...rstanding male infertility and could be used to de...ments according to a paper published by the journa...rticle demonstrates how proteomics, a relatively n... cell, can be successfully applied to infertility,...e dysfunctional. , "Up to 50 percent of male-fact...
Other Biology News:Researchers design artificial cells that could power medical implants 2Proteins in sperm unlock understanding of male infertility says new study 2
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Coating Solution Concentrate Kit from KPL
Biology Products: